Novanta (NASDAQ:NOVT – Get Free Report) issued an update on its second quarter 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.680-0.780 for the period, compared to the consensus EPS estimate of 375.000. The company issued revenue guidance of $230.0 million-$240.0 million, compared to the consensus revenue estimate of $240.7 million.
Analysts Set New Price Targets
Separately, Robert W. Baird dropped their target price on shares of Novanta from $169.00 to $160.00 and set a “neutral” rating on the stock in a research report on Monday, March 3rd.
Read Our Latest Research Report on NOVT
Novanta Stock Down 1.6 %
Novanta (NASDAQ:NOVT – Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The technology company reported $0.74 earnings per share for the quarter, beating analysts’ consensus estimates of $0.68 by $0.06. Novanta had a return on equity of 15.20% and a net margin of 6.52%. Equities research analysts expect that Novanta will post 3.03 earnings per share for the current year.
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
See Also
- Five stocks we like better than Novanta
- How to Use the MarketBeat Stock Screener
- Chevron’s Fundamentals Shine Through Market Turmoil
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Qualcomm: Analyst Opinions Split, But Upside Potential Remains
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Monster Beverage Stock: Short Report Risks vs Upside Potential
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.